Craft

JW Pharmaceutical

Stock Price

₩26.7 K

2024-10-29

Market Capitalization

₩620.2 B

2024-10-29

Revenue

₩775.3 B

FY, 2025

JW Pharmaceutical Summary

Company Summary

Overview
JW Pharmaceutical (formerly Choongwae Pharma) is a pharmaceutical company that develops antibiotics, intravenous solutions, and anti-cancer treatments. It provides a range of products, including amino acids, anticancer medications, anesthetics, antibiotics, respiratory treatments, etc.
Type
Public
Status
Active
Founded
1945
Website
http://www.jw-pharma.co.kr/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

JW Pharmaceutical Financials

Summary Financials

Revenue (FY, 2025)
₩775.3B
Gross profit (FY, 2025)
₩384.0B
Net income (FY, 2025)
₩61.5B
Cash (FY, 2025)
₩39.2B
EBIT (FY, 2025)
₩89.2B
Enterprise value
$635.6B

Footer menu